Time course of the effects of temocapril on cardiovascular structure and function in patients with essential hypertension

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 4, 1999, Pages 561-566

  Takata, Masanobu ^a   Ueno, Hitoshi ^a   Hirai, Tadakazu ^a   Oh hashi, Shinya ^a   Yasumoto, Kotaro ^a   Inoue, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Arterial distensibility; Essential hypertension; Left ventricular hypertrophy; Vascular hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; TEMOCAPRIL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; FOREARM BLOOD FLOW; HEART LEFT VENTRICLE MASS; HUMAN; MALE; PRIORITY JOURNAL; VASCULAR RESISTANCE;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CARDIOMEGALY; ECHOCARDIOGRAPHY; FEMALE; FOREARM; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLACEBOS; PLETHYSMOGRAPHY; THIAZEPINES; TIME FACTORS; VASCULAR RESISTANCE;

EID: 0032878856     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199910000-00013     Document Type: Article

References (43)

1. Folkow B. Hypertensive structural changes in systemic precapillary resistance: how important are they for in vivo haemodynamics? J Hypertens 1995;13:1546-59.
2. Korner PI, Bobik A, Angus JA, Friberg P. Resistance control in hypertension. J Hypertens 1989;7(suppl 4):125-34.
3. Mulvany MJ. Resistance vessel structure and the pathogenesis of hypertension. J Hypertens 1993;11(suppl 5):7-12.
4. Novo S, Abrignani MG, Corda M, Strano A. Cardiovascular structural changes in hypertension: possible regression during long-term antihypertensive treatment. Eur Heart J 1991;12(suppl G):47-53.
5. Lundin SA, Hallback-Nordlander MIL. Regression of structural cardiovascular changes by antihypertensive therapy in spontaneously hypertensive rats. J Hypertension 1984;2:11-8.
6. Opie L. ACE inhibitors, vascular structure, and arterial disease in hypertension. In: Opie L, ed. Angiotensin converting enzyme inhibitors: scientific basis for clinical use. 2nd ed. New York: John Wiley & Sons, 1994:239-67.
7. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies. Am J Hypertens 1992;5:95-110.
8. Cruickshank JM, Lewis J, Moore V, Dodd C. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 1992;6:85-90.
9. Schmieder RE, Martus P, Kingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies. JAMA 1996;275:1507-13.
10. Novo S, Abrignani MG, Liquori M, et al. Regression of structural vascular changes after chronic treatment in hypertensives. J Hypertens 1991;9(suppl 6):202-3.
11. Agabiti-Rosei E, Muiesan ML, Rizzoni D, et al. Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist, nitrendipine. J Cardiovasc Pharmacol 1991;18(suppl 5):S5-9.
12. Safar ME, Girerd X, Laurent S. Structural changes of large conduit arteries in hypertension. J Hypertens 1996;14:545-55.
13. Takemoto M, Egashira K, Usui M, et al. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 1997;99:278-87.
14. Rosendorff C. The renin-angiotensin system and vascular hypertrophy. J Am Coll Cardiol 1996;28:803-12.
15. Oizumi K, Koike H, Sada T, et al. Pharmacological profiles of CS-622, a novel angiotensin enzyme inhibitor. Jpn J Pharmacol 1988;48:349-56.
16. Sada T, Koike H, Miyamoto M. Long-term inhibition of angiotensin converting enzyme suppresses calcium channel agonist-induced contraction of aorta in hypertensive rats. Hypertension 1989;14:652-9.
17. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
18. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
19. Shahi M, Thorn S, Poulter N, Sever PS, Foale RA. Regression of hypertensive left ventricular hypertrophy and left ventricular diastolic function. Lancet 1990;336:458-61.
20. Greenfield ADM, Whitney RJ, Mowbay JF. Methods for the investigation of peripheral blood flow. Br Med Bull 1963;19:101-9.
21. Ueno H, Takata M, Oh-hashi S, et al. Regression of vascular structural changes and calcium metabolism in patients with essential hypertension after long-term monotherapy with enalapril. J Hum Hypertens 1993;7:125-30.
22. Kawasaki T, Sasayama S, Yagi S, Asakawa T, Hirai T. Non-invasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovasc Res 1987;21:678-87.
23. Hirai T, Sasayama S, Kawasaki T, Yagi S. Stiffness of systemic arteries in patients with myocardial infarction: a noninvasive method to predict severity of coronary atherosclerosis. Circulation 1989;80:78-86.
24. Snedecor GW, Cochran WG. Statistical methods. Ames, IA: The Iowa State University Press, 1967.
25. Dahlöf B, Herlitz H, Aurell M, Hansson L. Reversal of cardiovascular structural changes when treating essential hypertension: the importance of the renin-angiotensin-aldosterone system. Am J Hypertens 1992;5:900-11.
26. Yasumoto K, Takata M, Yoshida K, Mikawa M, Tomoda F, Sasayama S. Reversal of left ventricular hypertrophy by terazosin in hypertensive patients. J Hum Hypertens 1990;4:13-8.
27. Trimarco B, Wikstrand J. Regression of cardiovascular structural changes by antihypertensive treatment: functional consequences and time course of reversal as judged from clinical studies. Hypertension 1984;6(suppl III):150-7.
28. De Luca N, Rosiello G, Lamenza F, et al. Reversal of cardiac and large artery structural abnormalities induced by long-term antihypertensive treatment with trandolapril. Am J Cardiol 1992;70: 52D-9D.
29. Franz IW, Tonnesmann U, Muller JF. Time course of complete normalization of left ventricular hypertrophy during long-term antihypertensive therapy with angiotensin converting enzyme inhibitors. Am J Hypertens 1998;11:631-9.
30. Freslon JL, Giudicelli JF. Compared myocardial and vascular effects of captopril and dihydralazine during hypertensive development in spontaneously hypertensive rats. Br J Pharmacol 1983; 80:533-43.
31. Schiffrin E, Deng LY, Larochelle P. Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients. J Cardiovasc Pharmacol 1994;24(suppl 3):S51-6.
32. Schiffrin EL, Deng LY, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor: comparison with effects of a beta-blocker. Am J Hypertens 1995;8:229-36.
33. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995;25:474-81.
34. Agabiti Rosei E, Rizzoni D, Castellano M, et al. Media: lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995;13:341-7.
35. Agabiti-Rosei E, Muiesan ML, Rizzoni D, et al. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension. J Cardiovasc Pharmacol 1994;24(suppl A): S37-43.
36. Marceau M, Kouame N, Lacourciere Y, Cleroux J. Vascular structure in the forearm and calf after 6 months of angiotensin converting enzyme inhibition in elderly hypertensive subjects with left ventricular hypertrophy. J Hypertens 1998;18:673-9.
37. O'Rourke M. Mechanical principles in arterial disease. Hypertension 1995;26:2-8.
38. Benetos A, Albaladejo P, Levy BI, Safar ME. Acute and long-term effects of angiotensin converting enzyme inhibition on larger arteries and cardiac hypertrophy: mechanical and structural parameters. J Hypertens Suppl 1994;12:S21-9.
39. Keeley FW, Elmoselhi A, Leenen FHH. Enalapril suppresses normal accumulation of elastin and collagen in cardiovascular tissues of growing rats. Am J Physiol 1992;262:H1013-21.
40. Daemen MJAP, De Mey JGR. Regional heterogeneity of arterial structural changes. Hypertension 1995;25:464-73.
41. Linz W, Wiemer G, Scholkens BA. Contribution of bradykinin to the cardiovascular effects of ramipril. J Cardiovasc Pharmacol 1993;22(suppl 9):S1-8.
42. Waeber B, Brunner HR. Cardiovascular hypertrophy: role of angiotensin II and bradykinin. J Cardiovasc Pharmacol 1996;27 (suppl 2):S36-40.
43. Sada T, Koike H, Ikeda M, Sato K, Ozaki H, Karaki H. Cytosolic free calcium of aorta in hypertensive rat: chronic inhibition of angiotensin converting enzyme. Hypertension 1990;16:245-51.